Skip to main content
Fig. 4 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 4

From: Correlation between increased serum malondialdehyde and spectrum of cranial ultrasonography findings in hypoxic ischemic encephalopathy: could it be used as a predictor of disease severity?

Fig. 4

ROC curve analysis for discrimination between Sarnat stage II or III and Sarnat stage I patients using serum MDA levels. Cut-off MDA level is > 2.88 nmol/ml and area under the curve is 0.969. Sensitivity of MDA in Sarnat II or III compared to stage I was 90.62% and sensitivity was 100%

Back to article page